NPs Basic Information

Name
Ophiobolin Q
Molecular Formula C25H36O4
IUPAC Name*
(1R,3S,7R,8E,11S,12R)-12-[(Z,2S,5S)-5,6-dihydroxy-6-methylhept-3-en-2-yl]-1,4-dimethyl-6-oxotricyclo[9.3.0.03,7]tetradeca-4,8-diene-8-carbaldehyde
SMILES
CC1=CC(=O)[C@@H]/2[C@@H]1C[C@]3(CC[C@@H]([C@@H]3C/C=C2/C=O)[C@@H](C)/C=C\[C@@H](C(C)(C)O)O)C
InChI
InChI=1S/C25H36O4/c1-15(6-9-22(28)24(3,4)29)18-10-11-25(5)13-19-16(2)12-21(27)23(19)17(14-26)7-8-20(18)25/h6-7,9,12,14-15,18-20,22-23,28-29H,8,10-11,13H2,1-5H3/b9-6-,17-7-/t15-,18+,19+,20-,22-,23-,25+/m0/s1
InChIKey
ZCYAUPOUCSSQGA-WBBAMFPJSA-N
Synonyms
CHEMBL4550481; Ophiobolin Q; BDBM50523063
CAS NA
PubChem CID 73386894
ChEMBL ID CHEMBL4550481
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Sesterterpenoids
          • Direct Parent: Ophiobolane sesterterpeno

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 400.5 ALogp: 3.3
HBD: 2 HBA: 4
Rotatable Bonds: 5 Lipinski's rule of five: Accepted
Polar Surface Area: 74.6 Aromatic Rings: 3
Heavy Atoms: 29 QED Weighted: 0.52

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.747 MDCK Permeability: 0.00002820
Pgp-inhibitor: 0.111 Pgp-substrate: 0.947
Human Intestinal Absorption (HIA): 0.878 20% Bioavailability (F20%): 0.992
30% Bioavailability (F30%): 0.073

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.4 Plasma Protein Binding (PPB): 83.30%
Volume Distribution (VD): 1.064 Fu: 5.61%

ADMET: Metabolism

CYP1A2-inhibitor: 0.016 CYP1A2-substrate: 0.158
CYP2C19-inhibitor: 0.03 CYP2C19-substrate: 0.796
CYP2C9-inhibitor: 0.075 CYP2C9-substrate: 0.352
CYP2D6-inhibitor: 0.003 CYP2D6-substrate: 0.105
CYP3A4-inhibitor: 0.755 CYP3A4-substrate: 0.642

ADMET: Excretion

Clearance (CL): 6.123 Half-life (T1/2): 0.477

ADMET: Toxicity

hERG Blockers: 0.011 Human Hepatotoxicity (H-HT): 0.145
Drug-inuced Liver Injury (DILI): 0.299 AMES Toxicity: 0.049
Rat Oral Acute Toxicity: 0.903 Maximum Recommended Daily Dose: 0.958
Skin Sensitization: 0.822 Carcinogencity: 0.529
Eye Corrosion: 0.055 Eye Irritation: 0.02
Respiratory Toxicity: 0.987
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003777 0.828 D0N1TP 0.290
ENC003251 0.708 D0G5CF 0.250
ENC003687 0.594 D02ZGI 0.240
ENC005803 0.583 D0G8OC 0.234
ENC002982 0.582 D06JPB 0.234
ENC005044 0.571 D06AEO 0.231
ENC005045 0.524 D0P0HT 0.230
ENC002000 0.495 D01QUS 0.229
ENC003783 0.495 D04GJN 0.227
ENC005046 0.413 D0V2JK 0.226
*Note: the compound similarity was calculated by RDKIT.